Advances in Inflammasomes
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 20 August 2026 | Viewed by 1989
Special Issue Editor
Interests: inflammation; inflammasome; NLRP3; gasdermin; gastrointestinal cancers; viral vectors; signaling pathways; genome editing; light and electron microscopy; protein and nucleic acids quantification and analysis; flow-cytometer and cell sorting; cell death assay; immune cell isolation from tissue/biopsy; TRIM-away system; RNAi; cloning; gene overexpression; ELISA; cell biology; intracellular ion fluxes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is supervised by Dr. Roberto Negro and assisted by Dr. Valentina Arrè (National Institute of Gastroenterology “S. de Bellis”, IRCCS Research Hospital).
Inflammasomes are supramolecular cytosolic structures found in all innate immune cells, and they auto-assemble into micrometer-size complexes upon endogenous or exogenous insults, ultimately triggering the inflammatory response. By promoting the release of bioactive interleukin-1β and interleukin-18 into the bloodstream, inflammasomes detect and respond to a wide range of cellular stresses. Concomitantly, inflammasome activation culminates in a highly inflammatory form of programmed cell death, termed pyroptosis, which is mediated by a ring-shaped structure of Gasdermin proteins capable of permeabilizing the plasma membrane. However, the detailed molecular mechanisms underlying this process remain under intense investigation. Recent research has revealed the broader implications of inflammasome activity in human health and disease. Although an essential defense against infection, abnormal inflammasome activation is increasingly recognized as a contributor to complex diseases, including cancer, neurodegenerative diseases, metabolic syndromes, and autoimmune disorders. The integration of advanced omics technologies is revolutionizing our understanding of inflammasome biology, thus facilitating the discovery of novel small-molecule inhibitors and predictive biomarkers as well as paving the way for the development of tailored treatments based on patient’s inflammasome-related molecular profiles.
This Special Issue aims to provide a comprehensive overview of recent advances in inflammasome biology. We welcome original research articles, reviews, and short communications that explore the molecular mechanisms of inflammasome activation, its regulation, interaction with the microbiota, and its dual roles in health and disease. Particular interest will be given to translational and therapeutic perspectives, including novel inhibitors, biomarkers, and clinical implications.
By bringing together cutting-edge research in this field, we hope this Special Issue will offer new insights into inflammasome-mediated pathways and promote the development of innovative strategies to modulate inflammasome activity for therapeutic benefit.
We look forward to your contributions to this exciting and rapidly evolving area of immunology.
Dr. Roberto Negro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammasome
- pyroptosis
- innate immunity
- cancer
- neurodegenerative diseases
- microbiota
- gasdermin
- ninjurin
- drug screening
- personalized treatments
- multi-omics analysis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
